JP Morgan Initiates Albany Molecular Research At Overweight

Loading...
Loading...
Analysts at JP Morgan initiated coverage on shares of Albany Molecular Research
AMRI
with a Overweight rating. The target price for Albany Molecular Research is set to $25. Albany Molecular Research shares have jumped 74.22% over the past 52 weeks, while the S&P 500 index has surged 19.73% in the same period. Albany Molecular Research's shares gained 3.44% to close at $20.14 yesterday.
Posted In: InitiationAnalyst RatingsJP Morgan
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...